HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
GLOW BlendHPLC ≥ 99%MS confirmed70mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | GLOW Blend |
|---|---|
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Composition | GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg |
| Vial format | 70mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store the lyophilized blend at -20°C protected from light; stable at 2-8°C for short-term handling and transit. After reconstitution, keep at 2-8°C and minimize repeated freeze-thaw cycles. Ships with ice pack. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About GLOW Blend.
GLOW combines the copper-binding tripeptide GHK-Cu with the gastric pentadecapeptide BPC-157 and the thymosin β4-derived actin-binding peptide TB-500 in a single lyophilized vial. Each component is studied separately in tissue-repair, collagen and extracellular-matrix synthesis, angiogenesis and cell-migration research models; the blend co-formulates them for combined study workflows rather than as any therapeutic claim.
Documentation
Batch documentation support for GLOW Blend lots.
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the GLOW Blend reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
GLOW Blend — frequently asked by B2B buyers.
What is in the GLOW Blend and at what ratio?
GLOW co-formulates three research peptides in one 70 mg vial: GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. This is the single standard GLOW formulation we supply.
Does each component get its own purity documentation?
Yes. Every batch ships with a certificate of analysis reporting HPLC purity and mass-spec identity for each of the three peptides individually, alongside appearance and water-content data. Endotoxin and residual-solvent testing is available on request.
What vial size and minimum order apply?
GLOW is supplied only in the standard 70 mg vial format, with a minimum order of 1 kit (10 vials).
Can you private-label the standard GLOW formulation?
Yes. We support private labeling and custom packaging for the standard 70 mg GLOW formulation. The component ratio remains GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg.
Is GLOW Blend intended for therapeutic use?
No. It is supplied strictly for laboratory research and manufacturing use. It is not a drug, supplement or medical product, and we provide no dosing, medical or dosing guidance of any kind.
Related compounds